On-Demand Supplier Webinar
Data sheet
Id Counterfeit Pharmaceuticals with Portable Raman
Rigaku
in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.
India has grown into a major player in the pharma manufacturing sector and the scale and distribution of operations can be seen on the maps below. The maps were put together using 2007 data from the Directory of Pharmaceutical Manufacturing Units in India .
Note – since publication some people have questioned the accuracy of the Indian National Pharmaceutical Pricing Authority (NPPA) data used in the visualisations (see comment section). in-PharmaTechnologist is currently investigating the accuracy of the data.
Update 2nd June 2010 - the NPPA is in the process of finalising a new census of the Indian pharma industry. in-PharmaTechnologist plans to publish a new map when this becomes available.
Maharashtra is clearly the dominant force in both formulation and bulk drugs which is in keeping with its position as India’s leading industrial estate. Gujarat trails Maharashtra in both bulk drug and formulation but beyond this the situation is more varied.
For example, West Bengal has the third most formulation facilities, 694, but relatively few bulk drugs sites, with seven states having more of these plants. This is visualised on the chart below.
14 comments (Comments are now closed)
@Venky S Rao
Hi Venky,
Thanks for your comments. I have looked at state government websites for information but in general I have reservations about collating data in this manner.
Firstly, I have been unable to find data for every state. More importantly, the criteria used may differ from state-to-state.
Consequently, although the consensus appears to be that the data is flawed, when I created the visualisations I felt there were benefits to using a single source.
Since being alerted to potential flaws in the data I've been looking into the matter. This is ongoing and will hopefully result in information about the methodology of the NPPA and alternative data.
If/when I have this information I'll hopefully produce another article or visualisation.
Thanks again to everyone who has commented - your feedback will hopefully lead to a more comprehensive, accurate data set.
Nick
Report abuse
Posted by Nick Taylor
03 May 2010 | 15h58
Inaccurate
Information presented is incorrect, incomplete and inaccurate. AP followed by Gujarat has the highest number of API and formulation units. You may please cross check the details with the respective state government websites!
Report abuse
Posted by Venky S Rao
02 May 2010 | 03h06
In response...
Hi everyone,
Thanks for your comments.
Ross - thanks for taking the time to explain a little about the software.
Peter - glad I, and in-PharmaTechnologist, have helped you discover Tableau.
kvsngupta - we're looking into the validity of the data. To reiterate the figures are from the Indian government and listed on the websites of the Indian NPPA and Department of Pharmaceuticals.
I'm currently looking into the selection criteria used by the NPPA as this seems like a possible reason for the unexpected figures.
Cheers,
Nick
Report abuse
Posted by Nick Taylor
22 April 2010 | 09h14
Bulk drug mfg. units and Formulation units in Andhrapradesh
The statistics about number of Bulk drug units and Formulation units existing in Andhrapradesh state is totally wrong. Kindly get the information from DCA, Hyderabad , A.P. and update the same.
With regards
Report abuse
Posted by kvsngupta
22 April 2010 | 05h09
Downlaod this material (2)
I did downlaod the material and subsequently also the associated program Tableau Public. This program was completely free and is a delight to use and play around with. I am very happy that InPharma made this possible.
Report abuse
Posted by Peter Fontilus
21 April 2010 | 20h35
Anyone can access the .twbx for free
Hi, Ross from Tableau here.
Thanks for posting Nick, this is great data.
Just wanted to let you all know that anyone can access the .txbx file with our completely free program, Tableau Public. http://tableausoftware.com/public/ Furthermore, unlike other formats (pdf, image files), you can create your own visualizations. Give it a try!
Also, you can access the data in each visualization above by clicking on the part of the viz you are interested in and then clicking the arrow in the bottom toolbar. You can export tin four common formats.
Report abuse
Posted by Ross
20 April 2010 | 19h53
Data access and accuracy
Hi everyone,
2 points to make in this post.
Firstly, thanks for your comment Bruce. The download data option, and file type, is automatically inserted by the visualisation package.
I was aware very few people will have Tableau, and consequently wouldn't be able to open .twbx, so I linked to the original document in the article and in the comments. The data used is on P933 http://www.nppaindia.nic.in/Directory-NPPA.pdf
For anyone having difficulty opening the .pdf I've added the data into the article below the graph.
Also, if anyone who wants the data as an Excel file email me at nick.taylor@decisionnews.com and I'll send it over.
Hopefully everyone should be able to access the data in one of these ways.
2nd point
I've been in touch with contacts in India and they also feel that the figures for Andhra Pradesh appear to be too low.
As mentioned before, the data is from the Indian government. I'm currently looking into if the data is incorrect, and if it is, why.
If anyone has any insight into this area I'd be very grateful if you could send me an email or post a comment with your thoughts.
Also, the article has been amended to reflect questions about the accuracy of the NPPA data.
Thanks again to everyone who has contributed to this discussion.
Nick
Report abuse
Posted by Nick Taylor
20 April 2010 | 15h09
Download this material
Good morning Nick-
I'm assuming that you would not post material for download unless you wanted your readers to be able to do exactly this.
However, in an attempt to download, you are informed that this file is a .twbx extenison and can only be opened with this program for viewing.
I don't think readers should have to "download" special programs which very often charged for, which In Pharmicist should have converted to a commonly used file by the majority.
Many companies have restriction software on "downloading" anyting without administator rights.
Please re-submit your article with appropriate file format so the material can be of some value for distribution.
Regards
Report abuse
Posted by Bruce Schroepfer
20 April 2010 | 14h25
@Pumrao
Hi Pumrao,
Thanks for getting in touch. It appears several commentators have issues with the data.
As mentioned earlier I relied on data sourced by the Indian government (linked to in the article and comments) and would welcome being linked to alternate information.
The discrepancy between government data and the experience of commentators raises some interesting questions.
IF the data is incorrect:
How did the NPPA, a government agency, make mistakes?
What are the consequences for India, and its trade partners, when the agency charged with "the collection of data and statistics relating to the pharmaceutical industry" gets it wrong?
I welcome thoughts on any of the issues raised by this article, either in this comment section or by email: nick.taylor@decisionnews.com.
Thanks for your input,
Nick
Report abuse
Posted by Nick Taylor
20 April 2010 | 13h47
erroneous picture
It appears 2007 data on which the mapping was supposed to be done is erroneous. There are more units statistically in both API, dosage form space.
Most big blunder- Where is Andhra Pradesh in the chart" AP is a bulk drug capital of India and has many formulation units.
So also Karnatakas well as MP.
I am not writing more
Report abuse
Posted by pumrao
20 April 2010 | 12h51
@umesh
Hi Umesh,
Thanks for getting in touch. As I said to Tarun, if other data sets are available I'd be very grateful if you could link me to them. I'm working from the NPPA data which was the most recent, complete information I could source.
Regarding the companies you mention, the data includes Biocon, Jubilant, Cipla, Strides, Himalaya and Micro Lab facilities in Karataka. Plus, it also has DRL, Aurobindo, Matrix and Hetero sites in Andra Predesh.
The only company you mention not included in the data is Apotex. I'm aware Apotex has a presence in Karnataka and am unsure why it isn't included by the NPPA.
In the document the NPPA acknowledges the difficulties faced in compiling the 1st complete list of pharma manufacturing sites in India. Perhaps, Apotex slipped through the net somehow.
Cheers,
Nick
Report abuse
Posted by Nick Taylor
20 April 2010 | 09h20
Wrong Data-misleading
Andra Predesh and Karnataka , where big company 's lare operating is missing from data. Biocon , Apotex, jubliyant , cipla , strides , micro lab , himalaya arre operating in Karnataka . DRL , aurvindo , matrix , hetro and other 350 APi units are oeprating in Andra.
Report abuse
Posted by umesh
20 April 2010 | 06h34
@tarun
Hi Tarun,
Thanks for your comment. The figures used come from the Directory of Pharmaceutical Manufacturing Units in India. (P933 of http://www.nppaindia.nic.in/Directory-NPPA.pdf)
Could you tell me where your data comes from? It would be interesting to compare the 2 sources if there are major differences.
Thanks,
Nick
Report abuse
Posted by Nick Taylor
19 April 2010 | 14h26
the table is incorrect
Gujarat has 50% activity in Formulation and ~ 35% in API on all India basis. it is larger than Maharastra. double check.
Report abuse
Posted by tarun
19 April 2010 | 14h19
Read all comments (14)